Assessment of primary care practitioners' attitudes and interest in pharmacogenomic testing.
Citation: Pharmacogenomics. 21(15):1085-1094, 2020 10.PMID: 32969759Institution: MedStar Medical GroupDepartment: Assistant Vice President | Associate Dean for Research Development | MedStar Center for Successful Aging | MedStar Health | Pharmacogenomics | Vice PresidentForm of publication: Journal ArticleMedline article type(s): Journal ArticleSubject headings: *Attitude of Health Personnel | *Health Personnel/px [Psychology] | *Pharmacogenomic Testing/mt [Methods] | *Primary Health Care/mt [Methods] | *Surveys and Questionnaires | Female | Humans | Male | Nurse Practitioners/px [Psychology] | Pharmacogenetics/mt [Methods] | Physician Assistants/px [Psychology] | Physicians, Primary Care/px [Psychology] | Precision Medicine/px [Psychology]Year: 2020ISSN:- 1462-2416
Item type | Current library | Collection | Call number | Status | Date due | Barcode |
---|---|---|---|---|---|---|
Journal Article | MedStar Authors Catalog | Article | 32969759 | Available | 32969759 |
Aims: Identify the attitudes and interests of primary care providers (PCPs) in applying clinical pharmacogenomics (PGx) test results. Materials & methods: A questionnaire was designed and then disseminated to PCPs across the MedStar Health System. Results: Ninety of 312 (29%) PCPs responded and were included in analyses. Seventy-six (84%) had heard of PGx and 12 (13%) previously ordered PGx testing. Most, 68 (76%), believed PGx can improve care; however, a minority, 23 (26%), reported confidence in using PGx in prescribing decisions. Sixty-four (70%) wanted a pharmacist consultation. PCPs desired PGx for antidepressants (75%), proton pump inhibitors (72%) and other medications. Conclusion: Most PCPs felt unprepared to interpret PGx results and desired pharmacist consultations. These data can inform future PGx implementations with PCPs.
English